Layer by layer preparation of Fe(3)O(4)@Cg-DTC/AgNPs as colloidal antimicrobial and anti-biofilm agent

采用逐层法制备Fe(3)O(4)@Cg-DTC/AgNPs作为胶体抗菌剂和抗生物膜剂

阅读:1

Abstract

To solve antimicrobial resistance in bacteria, metal nanoparticles (NPs) have gained tremendous attention due to their effectiveness and ease of use. Here, we prepared a core-shell dithiocarbonate carbon functionalized magnetic composite and employed it to support and stabilize the silver nanoparticle (Ag NPs). A chemical reduction method was employed to decorate the Ag NPs over the surface of the magnetic composite. The prepared materials were characterized using FT-IR, XRD, VSM, EDX, SEM, TEM, particle size distribution analysis, and elemental mapping. The results demonstrated that the designed support effectively prevented aggregation of the Ag NPs, ensuring their uniform dispersion throughout the structure. The Ag NPs decorated core-shell material was used as an antimicrobial agent against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. The minimum inhibitory concentrations of nanocomposite against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus were 0.58 ± 0.38, 1 ± 0, and 4.67 ± 3.06 µg mL(-1), respectively. The results demonstrated that Fe(3)O(4)@C(g)-DTC/AgNPs nanocomposite has a stronger antibacterial effect than the control antibiotic, ciprofloxacin. Regarding biofilm inhibition, the lowest concentration of Fe(3)O(4)@Cg-DTC/Ag composite required to inhibit biofilm formation in E. coli was 0.0625 µg mL(-1), while the concentrations required for P. aeruginosa and S. aureus were 0.5 and 1 µg mL(-1), respectively. Cytotoxicity assays confirmed that the nanocomposite did not induce toxicity in NIH-3T3 cells. Overall, these results demonstrate the potent antibacterial and anti-biofilm activity of the Fe(3)O(4)@Cg-DTC/AgNPs nanocomposite while maintaining cytocompatibility.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。